AP
Insider
AH Bio Fund IV, L.P.
10% ownerAH Bio Fund IV, L.P. (10% owner) filed 1 Form 4 report as a reporting entity in the trailing twelve months (1 purchase, 0 sales), most often in Braveheart Bio, Inc. (BRVE). Across 1 priced purchase filing, the average 21-session return was -10.0% from execution and +5.0% from disclosure (delay-adjusted; derived). The largest single filing was $19.8M of BRVE (1,100,000 sh × $18.00, as filed), executed Aug 7.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
-10.0%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+5.0%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
4d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$19.8M
shares × price, as filed
Last traded
Aug 7
Filed Aug 11
Volume by month
Buys $19.8M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
BRVERecent filings
BRVEPURCHASE
Braveheart Bio, Inc.
View filing →
$19.8M1,100,000 sh × $18.00
Exec Aug 7
Filed Aug 11 · 5:53 PM ET